UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Subtypes of depressive symptoms and inflammatory biomarkers: An exploratory study on a sample of HIV-positive patients

Brain, behavior, and immunity, 2016-08, Vol.56, p.105-113

2016

Volltextzugriff (PDF)

Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic

The international journal of tuberculosis and lung disease, 2017-08, Vol.21 (8), p.852-861

2017

Volltextzugriff (PDF)

Public health implications of antiretroviral therapy and HIV drug resistance

JAMA : the journal of the American Medical Association, 1998-06, Vol.279 (24), p.1977

1998

Volltextzugriff (PDF)

Integrating tuberculosis and mental health services: global receptivity of national tuberculosis program directors

The international journal of tuberculosis and lung disease, 2019-05, Vol.23 (5), p.600-605

2019

Volltextzugriff (PDF)

Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004—2011

Clinical infectious diseases, 2012-05, Vol.54 (suppl 4), p.S245-S249

2012

Volltextzugriff (PDF)

Protease inhibitor resistance in HIV-infected patients: Molecular and clinical perspectives

Antiviral research, 2007-12, Vol.76 (3), p.203-221

2007

Volltextzugriff (PDF)

Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase

Antimicrobial agents and chemotherapy, 2003-11, Vol.47 (11), p.3377-3383

2003

Volltextzugriff (PDF)

A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug Penetration

CPT: pharmacometrics and systems pharmacology, 2017-07, Vol.6 (7), p.469-476

2017

Volltextzugriff (PDF)

Opportunities and challenges for transcriptome-wide association studies

Nature genetics, 2019-03, Vol.51 (4), p.592-599

2019

Volltextzugriff (PDF)

A low-cost, sustainable intervention for drinking reduction in the HIV primary care setting

AIDS care, 2006-08, Vol.18 (6), p.561-568

2006

Volltextzugriff (PDF)

Retroviral Biodiversity: Practical Consequences for HIV Treatment and Prevention

International journal of infectious diseases, 2008, Vol.12, p.e26-e27

Wainberg, M

2008

Volltextzugriff (PDF)

Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy

AIDS (London), 1998-09, Vol.12 (13), p.1619-1624

1998

Volltextzugriff (PDF)

Effects of drug resistance on viral load in patients failing antiretroviral therapy

Journal of medical virology, 2006-05, Vol.78 (5), p.608-613

2006

Volltextzugriff (PDF)

Transmission dynamics of the M184V drug resistance mutation in primary HIV infection

Journal of antimicrobial chemotherapy, 2011-10, Vol.66 (10), p.2346-2349

2011

Volltextzugriff (PDF)

Enhanced Fidelity of 3TC-Selected Mutant HIV-1 Reverse Transcriptase

Science (American Association for the Advancement of Science), 1996-03, Vol.271 (5253), p.1282-1285

1996

Volltextzugriff (PDF)

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

Antimicrobial Agents and Chemotherapy, 1993-10, Vol.37 (10), p.2231-2234

1993

Volltextzugriff (PDF)

The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection

Microbiological reviews, 1995-03, Vol.59 (1), p.63-93

1995

Volltextzugriff (PDF)

The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine

Antimicrobial Agents and Chemotherapy, 1993-06, Vol.37 (6), p.1390-1392

1993

Volltextzugriff (PDF)

Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-κB/Rel transcription factors

Microbiological reviews, 1995-09, Vol.59 (3), p.481-505

1995

Volltextzugriff (PDF)

Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine

Antimicrobial Agents and Chemotherapy, 1994-02, Vol.38 (2), p.275-281

1994

Volltextzugriff (PDF)

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

The New England journal of medicine, 2015-12, Vol.373 (23), p.2237-2246

2015

Volltextzugriff (PDF)

The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus

Journal of leukocyte biology, 1992-07, Vol.52 (1), p.111-114

1992

Volltextzugriff (PDF)

Clinical Significance of HIV Subtype Variability in Regard to Treatment Outcome

Clinical infectious diseases, 2015-05

Wainberg, M. A.

2015

Volltextzugriff (PDF)

The M184V Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Impairs Rescue of Chain-Terminated DNA Synthesis

Journal of Virology, 2000-04, Vol.74 (8), p.3579-3585

2000

Volltextzugriff (PDF)

Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription

Antimicrobial agents and chemotherapy, 1996-03, Vol.40 (3), p.527-540

1996

Volltextzugriff (PDF)

1 – 25 von 1.093

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(981)
Mit Volltextzugriff
(923)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Virology
(84)
Aids
(55)
Annals Of Oncology
(53)
Antimicrobial Agents And Chemotherapy
(38)
Journal Of Clinical Oncology
(37)
Antiviral Therapy
(22)
Plos One
(20)
The Journal Of Biological Chemistry
(20)
Virology
(16)
Aids Research And Human Retroviruses
(15)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Subtypes of depressive symptoms and inflammatory biomarkers: An exploratory study on a sample of HIV-positive patients

Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic

Public health implications of antiretroviral therapy and HIV drug resistance

Integrating tuberculosis and mental health services: global receptivity of national tuberculosis program directors

Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004—2011

Protease inhibitor resistance in HIV-infected patients: Molecular and clinical perspectives

Molecular impact of the M184V mutation in human immunodeficiency virus type 1 reverse transcriptase

A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug Penetration

Opportunities and challenges for transcriptome-wide association studies

A low-cost, sustainable intervention for drinking reduction in the HIV primary care setting

Retroviral Biodiversity: Practical Consequences for HIV Treatment and Prevention

Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy

Effects of drug resistance on viral load in patients failing antiretroviral therapy

Transmission dynamics of the M184V drug resistance mutation in primary HIV infection

Enhanced Fidelity of 3TC-Selected Mutant HIV-1 Reverse Transcriptase

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection

The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2',3'-dideoxy-3'-thiacytidine

Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-κB/Rel transcription factors

Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

The role of oxidative stress in disease progression in individuals infected by the human immunodeficiency virus

Clinical Significance of HIV Subtype Variability in Regard to Treatment Outcome

The M184V Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Impairs Rescue of Chain-Terminated DNA Synthesis

Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription

Suchergebnisse filtern